TOP PHARM LAB has a total of 11 patent applications. Its first patent ever was published in 1998. It filed its patents most often in France, Australia and Morocco. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are HLI CELLULAR THERAPEUTICS LLC, ELIASOF SCOTT and SYNOSIA THERAPEUTICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | France | 7 | |
#2 | Australia | 2 | |
#3 | Morocco | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Microorganisms | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Chatillon Jean | 10 |
#2 | Coupan Paul Ghislain | 10 |
#3 | Trinquier Murielle | 3 |
#4 | Mialaret Laurent | 1 |
#5 | Coupan Paul Chislain | 1 |
#6 | Grimaldi Jacques | 1 |
Publication | Filing date | Title |
---|---|---|
FR2972639A1 | Anti-inflammatory pharmaceutical composition | |
FR2927256A1 | Composition for the treatment of alfa-amylase respiratory tract inflammatory diseases and local anesthetics and method of preparing the same | |
FR2846881A1 | A composition used to prepare dentifrices comprises an amylolytic enzyme, especially alpha-amylase, to provide anti-inflammatory and bactericidal protection for the gums | |
FR2827776A1 | Composition comprising an enzymatic anti-inflammatory and a mucolytic | |
FR2802100A1 | Activated amylase | |
FR2800614A1 | Composition for the treatment of respiratory infections | |
FR2787331A1 | New formulation of alpha-amylase tablets |